8-K: KKR to Acquire Integer Holdings for $5.7 Billion

Integer Holdings Corporation has agreed to be acquired by an affiliate of KKR in an all-cash transaction valued at approximately $5.7 billion, with shareholders to receive $127 per share.

Summary

• Integer Holdings Corporation (ITGR) has entered into a definitive agreement to be acquired by an affiliate of Kohlberg Kravis Roberts & Co. L.P. (KKR).
• The transaction is valued at an enterprise value of approximately $5.7 billion.
• Integer stockholders will receive $127 per share in cash.
• This price represents a premium of approximately 51.8% to Integer's closing share price on April 29, 2026, and 28.8% to the 30-day VWAP as of July 31, 2026.
• The agreement follows a comprehensive strategic review initiated by Integer's Board of Directors.
• The transaction is expected to close by the end of the year, subject to customary closing conditions, including stockholder approval and regulatory approvals.
• Upon completion, Integer will become a privately held company, and its common stock will no longer be listed on the New York Stock Exchange.
• KKR intends to establish a broad-based employee ownership and engagement program at Integer post-acquisition.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a highly positive development, indicating a significant premium for shareholders and a strategic move by a reputable investment firm.

Positives

• Shareholders will receive a significant premium of $127 per share, reflecting a 51.8% increase over the pre-strategic review closing price.
• The all-cash transaction provides immediate and certain value to Integer stockholders.
• KKR's deep healthcare expertise and long-term vision are seen as beneficial for Integer's future growth and innovation.
• The acquisition is expected to provide Integer with additional flexibility and long-term capital for investment in capacity, technology, innovation, and talent.
• KKR plans to implement an employee ownership program, potentially benefiting the company's 11,000 associates.

Negatives

• Integer Holdings Corporation will cease to be a publicly traded company, meaning its common stock will no longer be listed on the New York Stock Exchange.
• The transaction may cause disruption to management's time from ongoing business operations.
• There is a risk that the transaction and its announcement could have an adverse effect on business relationships, including the ability to retain customers and key personnel.

Risks

• The transaction is subject to customary closing conditions, including the approval of Integer stockholders and receipt of required regulatory approvals.
• There is a risk that the parties may not be able to satisfy the conditions to the transaction in a timely manner or at all.
• Announcements related to the transaction could have adverse effects on the market price of Integer's common stock.
• The transaction could adversely affect business relationships, including the ability to retain customers, key personnel, and maintain supplier relationships.
• Potential litigation related to the transaction could be instituted against the Company or its directors and/or officers.
• Third-party contracts may contain provisions that require consent or are impacted by the transaction, which may not be waived or resolved.
• The Buyer's ability to obtain necessary financing arrangements is a condition.
• Various events could disrupt operations, including pandemics, cybersecurity attacks, or severe weather.

Future Outlook

Integer Holdings Corporation has withdrawn its previously issued financial outlook due to the pending acquisition by KKR. The company will not host its scheduled earnings conference call for the second quarter of 2026. KKR intends to invest in Integer's capacity, technology, innovation, and talent.

Management Comments

• "We believe this transaction recognizes the strength of Integers business, which includes our dedicated associates, our differentiated engineering and manufacturing capabilities, and our long-term growth opportunities, while providing stockholders with immediate and certain value."
• "KKRs deep healthcare expertise, long-term vision, and strategic growth orientation make them the right strategic partner to bring our business into its next chapter."
• "Together, we look forward to continuing to invest in our associates and capabilities to deliver excellence for our customers and advance our vision of improving patients lives."
• "Integer is an exceptional platform with highly differentiated capabilities across a global manufacturing footprint, a track record for quality and reliability, and a talented team operating in attractive, durable end-markets."
• "We are excited by the opportunity to deploy capital and resources to further advance Integers next chapter of growth and innovation."
• "We look forward to partnering with the management team and the 11,000 associates to build on Integers position as a trusted strategic partner to leading medical device companies and emerging innovators, helping bring life-saving and life-enhancing technologies to patients around the globe."
• "As a KKR portfolio company, Integer will have additional flexibility and long-term capital to invest in capacity, technology, innovation, and talent in support of its customers and the patients who rely on the products Integer helps bring to market."

Industry Context

StockSavvy.ai notes that this acquisition aligns with a broader trend of private equity firms actively acquiring established companies in the healthcare and medical device sectors, seeking to leverage their capital and expertise for growth and operational improvements. Integer, as a leading medical device CDMO, represents an attractive target due to its specialized capabilities and market position.

Corporate Governance

Legal Proceedings

• The filing mentions the potential for litigation related to the transaction that could be instituted against the Company or its directors and/or officers.

Related Party Transactions

• Information regarding the Company's transactions with related persons is set forth in its Form 10-K and 2026 Proxy Statement.

Stakeholder Impact

• Shareholders: Will receive $127 per share in cash, representing a significant premium.
• Employees: KKR intends to establish a broad-based employee ownership and engagement program.
• Customers: Integer will continue to operate as a strategic partner, with potential for increased investment in capabilities.
• Suppliers: Potential for disruption to business relationships, though KKR aims to build on existing partnerships.

Next Steps

• Integer stockholders will be asked to vote their shares to approve the transaction.
• The transaction requires the receipt of required regulatory approvals.
• Integer will become a privately held company upon completion of the transaction.
• KKR intends to establish a broad-based employee ownership and engagement program at Integer following the close of the transaction.

Key Dates

Recommendation

The acquisition at a significant premium provides immediate value to existing shareholders, making it a positive event. However, for potential investors, the stock will no longer be publicly traded, and the recommendation is to hold existing positions to realize the acquisition price, rather than initiating new positions in a soon-to-be-delisted company.

Keywords

Merger Agreement, Acquisition, Private Equity, Medical Device CDMO, Kohlberg Kravis Roberts, Integer Holdings Corporation, Shareholder Value, Strategic Review